Calli Lear
Impact in
- Infectious Diseases top 5%
- Viral Infections and Outbreaks Research
- Viral Infections and Vectors
- Viral gastroenteritis research and epidemiology
- SARS-CoV-2 and COVID-19 Research
- Emergency Medical Services top 5%
- Disaster Response and Management
Papers in
-
- Viral Infections and Outbreaks Research 5
- Viral gastroenteritis research and epidemiology 2
- Viral Infections and Vectors 2
- SARS-CoV-2 and COVID-19 Research 2
-
- Glutathione Transferases and Polymorphisms 1
- Co-authors
- Gene G. Olinger (6 shared papers)Corinne Scully (3 shared papers)Lisa E. Hensley (3 shared papers)Judith M. White (1 shared paper)Benjamin G. Hoffstrom (1 shared paper)Lisa M. Johansen (1 shared paper)Jennifer M. Brannan (1 shared paper)Sue E. Delos (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Antiviral Research (1 paper)Journal of Biological Chemistry (1 paper)Science Translational Medicine (1 paper)The Journal of Infectious Diseases (1 paper)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Calli Lear
6 papers receiving 699 citations
Peers
Comparison fields: 5 of 79
- Infectious Diseases 504
- Emergency Medical Services 66
- Biotechnology 77
- Epidemiology 197
- Virology 22
Countries citing papers authored by Calli Lear
This map shows the geographic impact of Calli Lear's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Calli Lear with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Calli Lear more than expected).
Fields of papers citing papers by Calli Lear
This network shows the impact of papers produced by Calli Lear. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Calli Lear. The network helps show where Calli Lear may publish in the future.
Co-authors
The 25 scholars most cited alongside Calli Lear, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 278 | |
| 2 | 2013 | 261 | |
| 3 | 2010 | 79 | |
| 4 | 2010 | 51 | |
| 5 | FGI-104: a broad-spectrum small molecule inhibitor of viral infection. | 2009 | 43 |
| 6 | 2009 | 26 |
About Calli Lear
Calli Lear is a scholar working on Infectious Diseases, Molecular Biology, Pediatrics, Perinatology and Child Health, Obstetrics and Gynecology and Public Health, Environmental and Occupational Health, having authored 6 papers that have together received 738 indexed citations. Recurring topics across this work include Viral Infections and Outbreaks Research (5 papers), Viral gastroenteritis research and epidemiology (2 papers), Viral Infections and Vectors (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Impact on Reproduction (1 paper), Glutathione Transferases and Polymorphisms (1 paper), Transgenic Plants and Applications (1 paper) and Mosquito-borne diseases and control (1 paper). The work is most often cited by research in Infectious Diseases (504 citations), Emergency Medical Services (66 citations), Biotechnology (77 citations), Epidemiology (197 citations) and Virology (22 citations). Calli Lear has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Gene G. Olinger, Corinne Scully, Lisa E. Hensley, Judith M. White, Benjamin G. Hoffstrom, Lisa M. Johansen, Jennifer M. Brannan, Sue E. Delos, Kathryn L. Schornberg and Lisa Evans DeWald. Their work appears in journals such as Proceedings of the National Academy of Sciences, Antiviral Research, Journal of Biological Chemistry, Science Translational Medicine and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.